Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.

Quotes for Double Bond Pharmaceutical International AB

Right Now

+/-
0.22
%
5,82%
Latest
4
High
4.15
Low
3.825
Volume
35 747
Turnover (SEK)
143 488
Value (MSEK)
98,4

Board

CEO

  • Igor Lokot

Chairman Of The Board

  • Per Stålhandske

Board

  • Igor Lokot
  • Lars Thomander
  • Sergey Yanitsky

Videos

Largest Owners

Name Capital % Votes % Date
Igor Lokot 40,42 56,38 2019-03-31
Avanza Pension 10,53 7,81 2019-09-30
Recall Capital Nordic AB 2,48 1,84 2019-09-30
Nordnet Pensionsförsäkring 2,21 1,64 2019-09-30
Obain AB 2,00 1,48 2019-09-30
Magnus Hamberg 1,98 1,47 2019-09-30
Rejo AB 1,45 1,07 2019-09-30
Per Ahlström 1,41 1,05 2019-09-30
Georgi Kalbin 0,92 0,68 2019-09-30
Investentia AB 0,86 0,64 2019-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2019-11-24 Delårsrapport 2019-Q3

  • 2020-02-25 Bokslutskommuniké 2019